166 related articles for article (PubMed ID: 12614867)
1. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
Vandevoorde S; Lambert DM; Smart D; Jonsson KO; Fowler CJ
Bioorg Med Chem; 2003 Mar; 11(6):817-25. PubMed ID: 12614867
[TBL] [Abstract][Full Text] [Related]
2. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.
Smart D; Jonsson KO; Vandevoorde S; Lambert DM; Fowler CJ
Br J Pharmacol; 2002 Jun; 136(3):452-8. PubMed ID: 12023948
[TBL] [Abstract][Full Text] [Related]
3. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
4. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
De Petrocellis L; Davis JB; Di Marzo V
FEBS Lett; 2001 Oct; 506(3):253-6. PubMed ID: 11602256
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D
Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933
[TBL] [Abstract][Full Text] [Related]
11. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).
Smart D; Gunthorpe MJ; Jerman JC; Nasir S; Gray J; Muir AI; Chambers JK; Randall AD; Davis JB
Br J Pharmacol; 2000 Jan; 129(2):227-30. PubMed ID: 10694225
[TBL] [Abstract][Full Text] [Related]
12. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.
Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D
Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856
[TBL] [Abstract][Full Text] [Related]
14. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
16. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
17. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
[TBL] [Abstract][Full Text] [Related]
18. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
19. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
20. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
